Merck has released positive results from a phase 3 study of its investigational oral antiviral COVID-19 drug Lagevrio (molnupiravir).
Most of us know someone affected by hearing loss, but we may not fully appreciate the hardships that lack of hearing can bring.
The U.S. Food and Drug Administration granted Fast Track designation for ASC Therapeutics’ ASC618, a second-generation gene therapy of hemophilia A.
The FDA has approved pilocarpine hydrochloride ophthalmic solution 1.25% (Vuity, Allergan, an AbbVie company) to treat presbyopia in adults.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.
